Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.
Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs
Maria Tiwari
Recently, a number of outstanding review articles covering a wide range of scientific and technological elements of bioanalysis have been published in the literature. Today, it is widely recognised that bioanalysis is essential for characterising novel chemical entities’ pharmacokinetic/pharmacodynamic properties, both at the time of their discovery and during the various stages of drug development that result in their approval for use in the marketplace. This collection examines important bioanalytical standards and how drug research and discovery processes might use them to produce safer, more affordable drugs. It is intended to offer some overarching concepts in this area that will act as the cornerstone of an all-encompassing framework for approaching bioanalysis from the inception (i.e., the identification of a lead molecule) and progressing through various phases of drug development.